Pestalozzi advises GTCR in the combination of Surgical Specialities and TachoSil to create Corza Medical
GTCR, a leading private equity firm, has simultaneously acquired and merged Surgical Specialties Corporation (“Surgical Specialties”) and the TachoSil® Fibrin Sealant Patch (“TachoSil”) to create a new company, Corza Medical. Surgical Specialties is a medical technology company focused on high-performance surgical sutures and ophthalmic knives, previously owned by a consortium led by ZQ Capital Limited and Vivo Capital LLC. TachoSil, previously owned by Takeda Pharmaceutical Company Limited, is a differentiated surgical patch product line used to enable safe and fast bleeding control during surgeries.
With a global team of over 1,700 employees supporting clinicians, distributors and medical device companies Corza Medical will provide healthcare professionals a platform of surgical technologies with industry-leading brands, including QuillTM barbed sutures, SharpointTM Plus and LookTM surgical sutures, Sharpoint ophthalmic knives, and the TachoSil fibrin sealant patch. Pestalozzi advised GTCR and Corza Medical as to all Swiss law aspects of the transaction.